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An Altered Position of the a2 Helix
of MHC Class I Is Revealed by the
Crystal Structure of HLA-B*3501
Kathrine J. Smith,*§ Scott W. Reid,² constraints, each MHC class Iallele iscapable of binding
a range of different peptides. Crystal structures of hu-David I. Stuart,²³ Andrew J. McMichael,*
man and murine MHC class I alleles complexed withE. Yvonne Jones,²³ and John I. Bell*
specific peptides have given insight into mechanisms*Molecular Immunology Group
by which variation in peptide length and sequence canNuffield Department of Clinical Medicine
be accommodated (Fremont et al., 1992, 1995; Matsu-Institute of Molecular Medicine
mura et al., 1992; Silver et al., 1992; Zhang et al., 1992;John Radcliffe Hospital
Madden et al., 1993; Collins et al., 1994, 1995; YoungOxford, OX3 9DU
et al., 1994). Each of the resultant spectrum of specificUnited Kingdom
peptide±MHC complexes presents a characteristic sur-²Laboratory of Molecular Biophysics
face for recognition by T cell receptors (TCRs). Several³Oxford Centre for Molecular Sciences
structural studies (Fremont et al., 1992, 1995; Zhang etDepartment of Biochemistry
al., 1992; Madden et al., 1993; Collins et al., 1994) haveThe Rex Richards Building
now demonstrated that, in the context of a particularUniversity of Oxford
allele, the exposed portions of the peptide can provideOxford OX1 3QU
the major contribution to the distinctive structural fea-United Kingdom
tures of the putative TCR binding surface. It has re-
mained less clear whether there is any significant poten-
tial for peptide-induced variation in the MHC class ISummary
molecule to contribute directly to the antigenic nature of
a specific peptide±MHC complex (Fremont et al., 1992;The crystal structure of the human majorhistocompat-
Madden et al., 1993).ibility complex class I B allele HLA B*3501 complexed
HLA-B*3501 (B3501), a common human class I allele,with the 8-mer peptide epitope HIV1 Nef 75±82
is a member of the B5 cross-reactive group (CREG),(VPLRPMTY) has been determined at 2.0 AÊ resolution.
which includes theclosely related alleles HLA-B53, HLA-Comparison with the crystal structure of the closely
B51, HLA-B52, HLA-B35, and HLA-B58 (Allsopp et al.,related allele HLA B*5301 reveals the structural basis
1991; Ooba et al., 1989; Hayashi et al., 1989, 1990; Wanfor the tyrosine specificity of the B*3501 F pocket.
et al., 1986). Sequence analysis shows that HLA-B53 isThe structure also reveals a novel conformation of the
identical to HLA-B3501 except for a short region at the8-mer peptide within the binding groove. The positions
39 end of exon 2. Thus, both alleles share identical a2of the peptide N and C termini are nonstandard, but
and a3 domains but differ for five residues of the a1the classic pattern of hydrogen bonding to nonpoly-
domain; amino acids 77, 80, 82, 82, and 83 (Figure 1A).morphic MHC class I residues is maintained, at the N
This variation was originally detected as a difference interminus by addition of a water molecule, and at the
the serological properties of the alleles, with the HLA-C terminus by a substantial shift in the a2 helix.
B53 sequence specifying a Bw6 rather than a Bw4 motif
(Allsopp et al., 1991), and forms part of the class I mole-Introduction
cule that has been inferred to be involved in interaction
with natural killer (NK) cell receptors (Raulet and Held,
The recognition by T cells of major histocompatibility
1995). We have recently determined the crystal structure
complex (MHC) class I alleles complexed with peptide
of HLA-B53 (Smith et al., 1996 [this issue of Immunity])
antigen is a critical event in the initiation of an immune and mapping of the B3501-specific polymorphic resi-
response (Bjorkman and Parham, 1990). The crystal
dues onto this structure indicates that they cluster
structure of a class I allele, HLA-A2 (Bjorkman et al.,
around the F pocket (Figure 1B), the end of the peptide-
1987), showed that the peptide binds in a groove formed
binding groove that accomodates the peptide C termi-
by the a1 and a2 domains. Sequencing of pools of pep- nus (PC). Sequencing of peptide pools eluted from
tides eluted from class I alleles (Falk et al., 1991), and B3501 has revealed a peptide-binding motif with a
crystal structures of the human class I alleles HLA-A2, strong preference for Pro at position 2 (P2) and Tyr at
HLA-A68, and HLA-B27 complexed with heterogenous PC (Hill et al., 1992; Falk et al., 1993). This is in contrast
populations of peptides (Bjorkman et al., 1987; Garrett with the peptide-binding motif for HLA-B53 (Hill et al.,
et al., 1989; Saper et al., 1991; Madden et al., 1991, 1992; 1992), which has a strong preference for Pro at P2 but
Guo et al., 1992), has revealed the general principles for a broad specificity for the PC (Leu, Ile, Val, Phe, Tyr).
peptide binding. Peptides are held in the binding groove These pool sequence data, combined with the primary
by a conserved network of hydrogen bonds at both their sequence information for the two alleles, imply that
N and C termini and by conserved anchor residues, some or all of the five polymorphic residues that are
which fit into pockets formed by polymorphic MHC side different between HLA-B53 and HLA-B3501 are respon-
chains. Within the limits set by these primary structural sible for the change in specificity of the F pocket but
exert no effect on the specificity for a P2 Pro at the B
pocket (situated towards the opposite end of the pep-§Current address: Howard Hughes Medical Instituteand Laboratory
tide-binding groove).of Molecular Medicine, Children's Hospital, Boston, Massachusetts
02115. The crystal structure of HLA-B53 demonstrated how
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Figure 1. Location of HLA-B3501 Polymorphic Residues
(A) A section of the sequence alignment for some members of the B5 CREG. The five residues (77, 80, 81, 82, and 83) between B3501 and
B53 that are different are shown in the boxed region.
(B) The location of the five B3501 polymorphic residues (red) on the main chain structure of the B53 peptide-binding groove. These residues
are located on the a1 helix in the region of the F pocket.
the Pro anchor residue at P2 is accommodated in the Results
B pocket and how the broad specificity of the F pocket
is facilicated (Smith et al., 1996). To determine the struc- Overall Structure
The HLA-B3501/Nef complex was prepared using a re-tural basis for the strong preference for a Tyr at the PC,
the crystal structure of HLA-B3501 complexed with the folding protocol based on that of Garboczi et al. (1992);
the specific synthesized peptide corresponding to resi-HIV1 Nef 75±82 epitope (VPLRPMTY) (Culmann-Pencio-
lelli et al., 1994) has been determined to 2.0 AÊ resolution. dues 75±82 of HIV1 Nef (VPLRPMTY) was combined
with HLA-B3501 heavy chain (residues 1±276) and b2-The HIV1 Nef peptide is an immunodominant epitope
presented by HLA-B3501 to cytotoxic T lymphocytes microglobulin (b2m) (residues 1±99) produced separately
in Escherichia coli expression systems. The complexand titres out to nanomolar concentrations in these
assays (Rowland-Jones et al., 1995). The structure of crystallized in the space group P212121 with unit cell
dimensions a 5 51.3 AÊ , b 5 82.7 AÊ , c 5 108.6 AÊ . Molecu-the HLA-B3501/Nef peptide complex is the first for an
octamer peptide bound to a human MHC class I mole- lar replacement and crystallographic refinement using
X-ray diffraction data to 2.0 AÊ resolution resulted in thecule. A detailed comparison of the B3501 and B53 struc-
tures reveals the structural basis of the different speci- current crystal structure, which contains residues 1±276
of the B53 heavy chain, residues 1±99 of b2m, and resi-ficity of the F pockets. In addition, the B3501 structure
reveals a novel peptide conformation and a surprising dues 1±8 of the peptide. The R value for the final model
(with a bulk solvent correction) is 20.3% on all data frompeptide-dependent alteration in position of the N-termi-
nal segment of the a2 helix. 10±2.0 AÊ with stereochemistry typified by root-mean-
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square (rms) deviations from ideal bond lengths and B3501 F pocket approximately 1±1.5 AÊ (equivalent to
bond angles of 0.013 AÊ and 1.668, respectively. An omit half an amino acid length) nearer to the A pocket and
map for the peptide is displayed in Figure 2A. The overall 0.5 AÊ closer to the a1 helix than in other MHC class
structure of HLA-B3501 is similar to that of the pre- I±peptide structures (see Figure 2). Hydrogen bonds that
viously determined human and murine class I alleles. hold the PC in the F pocket are made between con-
The quaternary structure shows closest agreement with served MHC side chains Tyr84, Thr143, Lys146, and
that of HLA-B53 (rms deviation of 0.54 AÊ for superposi- Trp147 and peptide main chain atoms (Madden et al.,
tion of all Ca atoms). 1992). In the B3501 structure, an additional hydrogen
bond is made between the peptide C-terminal carboxyl
group and Asn80, a B3501-specific polymorphism. This
Peptide Structure: Nonstandard further stablizes the PC and may contribute to its loca-
N- and C-Terminal Positions tion towards the a1 helix.
The majority of MHC class I peptide complexes studied
to date are for 9-mer peptides (Madden et al., 1993;
Silver et al., 1992; Fremont et al., 1992). Two shorter The F Pocket: Anchor Specificity
8-mer peptides have been analyzed bound to the murine The five polymorphic residues that are different between
allele H-2Kb (Fremont et al., 1992, 1995); however, they B53 and B3501 are clustered in the region of the F
differ from most human class I binding peptides in hav- pocket and result in a change in specificity of this pocket
ing anchor residues in the central region. The positioning for the PC. Whereas HLA-B53 can accomodate a broad
of the 8-mer Nef peptide (VPLRPMTY) N and C termini range of C-terminal hydrophobic and aromatic side
complexed with B3501 is notably different from all the chains, B3501 exhibits a strong preference for a Tyr at
other peptides yet reported in complex with murine and the PC (Hill et al., 1992; Falk et al., 1993). The structure
human MHC class I alleles (Figures 2B and 2C). of B3501 shows that the specificity for a C-terminal Tyr is
The Nef peptide N terminus is positioned 1.5 AÊ higher due to modifications in the architecture of the F pocket,
in the B3501 A pocket than the standard N-terminal which favorably positions the Tyr hydroxyl group to hy-
position. This is facilitated by a water molecule, which drogen bond to both Ser116 at the base of the groove
occupies a position equivalent to the N-terminal nitro- and Tyr74 on the a1 helix (Figure 4). Three of the B3501
gen of other peptides complexed with MHC class I al- polymorphic residues contribute to this specificity either
leles (Figure 3). This water molecule allows hydrogen sterically or electrostatically. Positions 77 and 81 affect
bonds from conserved MHC side chains to peptide main the specificity through steric factors, while position 80
chain atoms to be maintained. These hydrogen bonds has an electrostatic effect. The relatively small Ser resi-
hold the peptide N terminus in the A pocket and are due at 77 (Asn in B53) allows a hydrogen bond to be
observed in all MHC class I structures determined to
made via a water molecule to the P6 carbonyl group
date. As a result of the raised position of the peptide N
while increasing the available volume of the F pocket;
terminus in the A pocket, the Pro anchor at P2 also sits
this allows the bulky Tyr aromatic ring to be accommo-
higher in the B pocket. This has a negligible effect on
dated in an orientation that is rotated compared with
the architecture of the B pocket so that, as in B53 com-
the PC Phe in B53 (Smith et al., 1996). Asn80 (Ile in
plexes, the Pro packs against Tyr7 and Phe67 in a shal-
B5301) hydrogen bonds to the C-terminal carboxyl
low hydrophobic pocket lined by residues Tyr7, Tyr9,
group, adding an additional hydrogen bond to the con-Asn63, Ile66, Phe67, and Tyr99 (Smith et al., 1996). The
served hydrogen bonding network of the F pocket andpeptide main chain from P3 to P4 is held by conserved
biasing the position of the C terminus slightly towardshydrogen bonds from Tyr9 via Tyr99 to the P3 main
the a1 helix. Leu81 (Ala in B53) is an important stericchain nitrogen and from Tyr9 and Asn70 via a water
polymorphism. In B53, Ala81 allows the bulky P9 Phemolecule to the P3 mainchain oxygen, facilitating a
to fill the F pocket and pack against Tyr123 and Asn77,mainchain kink between P3 and P4, characteristic of
while in B3501, Leu81 fills the end of the F pocket andhuman MHC class I complexes, which causes the pep-
the PC Tyr is repositioned to hydrogen bond to Ser116tide to arch up and out of the groove. The angle of
and Tyr74. In contrast, the polymorphic residues at posi-this kink in the Nef peptide is, however, nonstandard.
tions 82 and 83, Arg and Gly, respectively (Leu andCompared with other human MHC class I±peptide struc-
Arg in B53), are solvent exposed and do not appear totures, the apex of the kink at P4, is positioned 1±1.5 AÊ
contribute to the specificity of the F pocket.lower in the groove and 1.5 AÊ closer to the F pocket than
These results show that the Tyr specificity of thehas previously been observed for similarly anchored
B3501 F pocket arises from the ability of the Tyrhydroxylpeptides (8-mer peptides bound to the murine allele
group to hydrogen bond to both Ser116 and Tyr74. ThisH-2Kb are positioned even lower butuse anchor residues
is attributable directly to the polymorphic residues atfrom the central region of the peptide). A rigid body
positions 77, 80, and 81. Ser77 and Leu81 act stericallyrotation and translation is all that is required to superim-
by stabilizing theTyr inan optimal position for this hydro-pose the Nef peptide P1±P4 main chain identically onto
gen bonding to occur and Asn80 acts electrostaticallythe P1±P4 main chain of other peptides complexed with
by providing an additional hydrogen bond to the PC. InMHC class I alleles. Thus, the conformation of P1±P4 in
B53, a water molecule is located in the same positionthe peptide is standard for MHC class I peptide com-
as the Tyr hydroxyl group in B3501, therefore satisfyingplexes but is presented in an altered context relative to
the hydrogen bonding requirements of Ser116 andthe MHC molecule.
The C terminus of the Nef peptide is positioned in the Tyr74.
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Peptide-Dependent MHC Mainchain Conformation have been determined to date reveals an alteration in
position of the N-terminal region of the a2 helix (FigureComparison of the main chain structure of HLA B3501
with the main chains all other MHC class I alleles that 5). The change in position of the a2 helix is from residues
Crystal Structure of MHC Class I HLA-B3501
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Figure 2. The Structure of the HIV1 Nef Peptide (VPLRPMTY)
The views illustrate the peptide viewed through the a2 helix.
(A) A 2.0 AÊ |Fo|2|Fc| wcalc electron density map for which the Nef peptide has been omitted from the phasing model. The electron density is
contoured at 2.5 s and displayed in FRODO (Jones, 1985) with the current model for the peptide.
(B) A main chain superposition (SHP, Stuart et al., 1979) of the Nef peptide (light blue) with the peptide main chains from the following
structures: HLA-B53/ls6 (red), HLA-B53/HIV2 (purple), H-2Kb/VSV8 (dark blue), HLA-A2/flu (dark green), H-2Kb/SEV9 (yellow), H-2Db/Flu-np
(light green).
(C) A superposition of the Nef peptide (green) with the ls6 peptide KPIVQYDNF (red) from the B53/ls6 structure.
141±152 and is some four to five times greater (1.5 AÊ ) observed with B3501, combined with the smaller shifts
previously noted in other class I structures, suggeststhan the coordinate error (0.27 AÊ , estimated from the
average discrepancy in a Ca superposition of b2m be- that the shorter N-terminal region of the a2 helix is able
to move as a rigid body in response to variation in thetween HLA-B3501 and B53). The concerted shift in this
region of the a2 helix correlates with the translation of nature and position of the C terminus of the peptide.
In contrast with the large alteration in main chain posi-theNef PC along the length of the groove and is therefore
likely to be attributable directly to the alteration in posi- tion of the HLA-B3501 a2 helix, only a small deviation
in position, close to the coordinate error of the system,tion of the PC. Conserved hydrogen bonds are made
from Lys146, Trp147, and Thr143 to the peptide main is observed in the a1 helix from residues 56±62 on com-
parison with other MHC class I structures. It is unclearchain in the region of the F pocket. The alteration in
position of the PC appears to pull the N terminus of the whether this comparative shift is due directly to the
conformation of the peptide or due to small differencesa2 helix with it in order to maintain these hydrogen
bonds (Figure 5). This movement of the a2helix isconso- in contacts with neighboring molecules in the crystal.
Unlike the correlation between the reorientation of thenant with the trends already suggested for the binding
of different peptides to the same allele (H-2Kb, HLA-A2, a2 helix and the position of the PC, the reorientation of
the peptide N terminus does not appear to be directlyand HLA-B53), where much smaller shifts, close to the
coordinate error of the system, were observed (Fremont related to the shift in the a1 helix. The reorientation
of the peptide N terminus involves a rotation, so thatet al., 1992; Madden et al., 1993; Smith et al., 1996).
The movement of this part of the a2 helix is probably although the height of the peptide above the base of
the groove in the A pocket is greater than for otherfacilitated by the kink in the helix that occurs in the
region 149±152 and effectively divides the a2 helix into class I binding peptides, the peptide N terminus is not
translated significantly along the length of the groovetwo parts, a shorter region from residues 138±149 and
a longer region from residues 152±180. The a2 helix shift and the position of a water molecule negates the need
Immunity
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Figure 3. The A Pockets of B3501 and B53
The MHC main chain is represented in green, key side chains are shown in white, dashed lines indicate hydrogen bonds, and light blue
spheres mark the positions of tightly bound water molecules. In both panels, the peptide is viewed through the a2 helix.
(A) The B3501/Nef A pocket.
(B) The A pocket of the B53/ls6 complex.
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Figure 4. The F Pockets of B3501 and B53
Both panels are viewed through the a2 helix and, as in Figure 3, the MHC main chain is represented in green, key side chains are shown in
white, dashed lines indicate hydrogen bonds, and light blue spheres mark the positions of tightly bound water molecules.
(A) The B3501 F pocket. The polymorphic residue (Gly) at position 83 is not visible from this angle but is solvent exposed and located on a
turn of the a1 helix adjacent to residue 82.
(B) The B53 F pocket.
Immunity
210
Figure 5. A Superposition of the N-Terminal Region of the HLA-B3501 and B53 Peptide-Binding Groove
The view is from above the peptide-binding groove with the a1 helix at the top of the page, and shows a superposition of the B3501/Nef
(blue) and B53/ls6 (light green) a1a2 domains (SHP, Stuart et al., 1979). The main chains of the Nef and ls6 peptide are shown in blue and
light green, respectively; hydrogen bonds are indicated as dashed lines and key side chains from B35 (blue) and B53 (light green) are labeled.
The a1 helix of the two structures (top) shows no significant deviation above the coordinate error of the system and is shown in blue. The
significance of the movement of the a2 helix in B3501 is reinforced by consideration of the crystal lattice. The size of the lattice in B3501 is
within the span of sizes sampled in crystals of B53 (Smith et al., 1996), which have the same points of contact between neighboring molecules
but do not show any significant movement of the a2 helix.
for any shift in the helix to maintain hydrogen bonding. underscoring the important role played by water mole-
Instead, as discussed for HLA-B53 (Smith et al., 1996), cules in facilitating the binding of peptides of diverse
it is possible that the position of the P5 residue may sequence to class I alleles, as discussed in Smith et al.
influence this region of the a1 helix. (1996). At the C terminus, the Nef peptide falls 1±1.5 AÊ
short of the usual C-terminal position in the groove and
is linked to an alteration in theMHC main chain structure.Discussion
Thus, in the 8-mer peptide both termini are ªpulledº
towards the centre of the peptide compared with longerComparison of the structure of the 8-mer Nef peptide
9-mer and 10-mer peptides. This is in contrast with thewith that of longer 9-mer and 10-mer peptides com-
binding of 8-mer peptides to the murine allele H-2Kbplexed with class I alleles highlights a novel positioning
(Fremont et al., 1992, 1995), where a significant alter-of the peptide N and C termini. At both termini, different
ation in the N and C terminal position of the peptidesmechanisms act to compensate for an overall loss in
is not observed (Figure 2B). This difference is due tolength of an amino acid (3.5 AÊ ), while preserving hydro-
different hydrogen bonding constraints in the centralgen-bonding networks in both the A and F pockets,
region. The central anchor (PC-3) for the murine allelewhich are crucial for holding the peptide in place. At the
H-2Kb lowers the height of the peptide in the grooveN terminus, this is achieved by adding a water molecule
and reduces the P3±P4 main chain kink characteristicin the A pocket; this allows the peptide to pivot about
of human alleles. Thus, the novel water-mediated posi-the P2 anchor position to reposition the P3±P4 kink
tioning of the Nef peptide N terminus could representlower in, and further along, the binding groove. This
a general binding characteristic of short peptides withextra water molecule in the A pocket is in a similar
primary anchor residues at the P2 and PC positions. Itposition to the water molecule in the A pocket of the
is as yet unclear whether the novel architecture of the Fnonclassical class Ib molecule H2-M3 complexed with
the formylated peptide fMYFINILTL (Wang et al., 1995), pocket of HLA-B3501 imposes a preference for octamer
Crystal Structure of MHC Class I HLA-B3501
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peptides; initial analysis of epitope peptides has re- the cell (Hill et al., 1993), folding within a few minutes.
Second, it has been found to associate poorly with thevealed a relatively high frequency (about half) of octamer
peptides compared with other HLA class I molecules endoplasmic reticulum luminal part of TAP, in contrast
with HLA-A2 and HLA-B8, which associate avidly (J.(Rammensee et al., 1995).
Consideration of the structure of HLA-B3501 in the Neefjes, personal communication). It is possible that a
poor association with TAP results from the a2 helix shift.context of the previously determined structure of the
closely related allele HLA-B53 reveals the structural ba-
Experimental Proceduressis for the Tyr specificity of the B3501 F pocket. The
structure of HLA-B53 showed that the broad specificity
Protein Production and Crystallizationof the B53 F pocket was due to the small Ser at position
A full-length HLA-B3501 cDNA clone was prepared from B3501 T2
116 at theapex of thepocket, which opened theF pocket transfectants (a gift from M. Takiguchi). The B3501 expression vec-
to the region of structural plasticity in the central region tor was constructed by polymerase chain reaction (PCR) of the gene
of the binding groove (Smith et al., 1996). HLA-B3501, fragment containing the coding region for residues 1±276, using
the primers 59-GCGCGGATCCCACTCCATGAGGTATTTC-39 and 59-in contrast, exhibits a strong preference for a Tyr at the
GCGCAAGCTTTTACTATGGCTCCCATCTCAGGGTGAGGGGCTTPC (Hill et al., 1992; Falk et al., 1993), and we now see
CGG-39. The resulting fragment was cut with the restriction enzymesthat 3 of 5 polymorphic residues (Ser77, Asn80, and
BamHI and HindIII and cloned into the expression vector pGMT7 (a
Leu81) contribute directly to this change in specificity pET derivative; Studier et al., 1990). The expression plasmid was
both sterically and electrostatically. The resultant form transformed into the E. coli strain BL21(DE3)pLysS (Novagen) and
of the F pocket allows the PC Tyr hydroxyl group to grown at 378Cin Luria±Bertanimedium containing20 mg/ml carbeni-
cillin (Sigma). HLA-B3501 heavy chain was expressed and isolatedhydrogen bond to Ser116 and Tyr74 at the base of the
as described for HLA-B53 heavy chain (Smith et al., 1996). A dilutionpocket and therefore constitutes the basis of the speci-
method of refolding (Garboczi et al., 1992) was used to generate aficity. This architecture clamps the Tyr PC side chain
specific HLA-B3501/Nef complex from denatured HLA-B3501 heavy
back along the groove relative to PC side chains in other chain and b2m (produced using the vector pHN1b2m; a gift from D.
alleles. The two polymorphic residues at positions 82 Garboczi) and synthesized peptide. After refolding, the solution was
and 83 (Arg and Gly) are solvent exposed and do not concentrated and purified by gel filtration on an FPLC system (Phar-
macia) in 20mM Tris (pH 7.5), 150 mM NaCl. The B3501±Nef complexappear to affect the F pocket directly; however, as sur-
(8 mg/ml in 25 mM Na cacodylate [pH 6.5]) crystallized at 218C asface residues they are likely to contribute not only to
thick plates (0.3 mm 3 0.2 mm 3 0.2 mm) by streak seeding withthe serological differences between the two alleles but
B53/ls6 crystals (Reid et al., 1996). Drops contained a 1:1 ratio of
also to the NK cell receptor recognition surface. protein and reservoir solution suspended above a reservoir of 0.1
The crystal structure of HLA B3501 reveals a suprising M Na cacodylate (pH 6.5) and 18% PEG8000. For cryocrystallography,
alteration in position of the region of the a2 helix from crystals were transferred to reservoir solution containing an addi-
tional 25% glycerol.residues 141±152 on comparison with the main chain
structure of HLA-B53 and other MHC class I alleles. This
Data Collection and Processingcorrelates with the nonstandard position of the PC. To
The HLA-B3501/Nef complex crystallized in the space group P212121maintain the conserved hydrogen bonding network of with unit cell dimensions a 5 51.3 AÊ , b 5 82.7 AÊ , c 5 108.7 AÊ . Data
the F pocket, which is crucial to hold the peptide in the collection was carried out on cryo-cooled crystals at beamline 1
binding groove, the N-terminal region of the a2 helix is of the European Synchrotron Research Facility, Grenoble (l 5 0.96
AÊ ), utilizing a MAR-research imaging plate system (30 cm diameter).pulled in the direction of the peptide. The shift in position
A single cryo-cooled crystal was used for collection of a full data setof the a2 helix is probably facilitated by the kink in this
(177209 observations for 32001 unique reflections yielding 95.2% ofhelix (present in all MHC class I structures, centered
the possible data from 10±2.0 AÊ resolution). The diffraction data were
on residues 149±152), which divides the helix into two autoindexed, integrated and corrected for Lorentz and polarization
regions (a shorter region from residues 138±149 and a effects with the program DENZO (Otwinowski, 1993), followed by
longer region from residues 152±180). This enables the scaling and merging in SCALEPACK (Otwinowski, 1993).
shorter N-terminal region to move as a rigid body in
Molecular Replacement and Refinementisolation of the longer C-terminal helical region, which
A molecular replacement solution for the B3501±Nef complex wasis tethered to the floor of the peptide-binding groove by
obtained using the HLA-B53±ls6 crystal structure (excluding pep-a disulfide bond. This suggests that the N-terminal re-
tide; Smith et al., 1996) in program XPLOR (Brunger, 1992). Rigid
gion of the class I a2 helix is capable of a substantial body refinement of this solution in XPLOR yielded an R factor of
shift in response to an alteration in sequence or length 42.3% on data from 8.0±4.0 AÊ resolution and Fo±Fc and 2Fo±Fc maps
of the bound peptide. Since the a2 helix of B3501 is were calculated on the basis of these phases (electron density map
calculations were performed with the CCP4 programs; CCP4, 1994).identical to that of B53, it is clear that the movement
These maps showed clear electron density for the peptide and facili-of the N-terminal region is directly dependent on the
tated the manual rebuilding of the MHC model (program FRODO;nonstandard positioning of the Nef PC.
Jones, 1985) with the correct B3501 sequence and inclusion of
Finally, what might be the significance of this a2 short the Nef peptide (VPLRPMTY). The structure was further refined in
helix shift in the function of HLA B3501? The results XPLOR: conjugate gradient minimization: 250 cycles on 10.0±3.0 AÊ
presented here provide evidence for the involvement resolution data, 250 cycles on 10.0±2.3 AÊ resolution data, followed
by restrained temperature factor refinement and a standard slow-of the MHC main chain, in addition to the peptide, in
cool protocol: 3000 K to 200 K using 10.0±2.3 AÊ resolution datadetermining the antigenic identity of a peptide±MHC
(Bruger and Krukowski, 1990). A bulk solvent correction, as imple-complex. It is also possible that the inherent ability of
mented in version 3.1 of XPLOR (Brunger, 1992), allowed all mea-
a region of the a2 helix to shift position may be important sured data from 10.0±2.0 AÊ to be incorporated into the refinement.
in assembly of the class I±peptide complex. In this re- Several further rounds of model building and refinement yielded the
spect, the HLA-B3501 molecule has been shown tohave final model with an R factor of 20.3%. The final model exhibits good
stereochemistry (Engh and Huber, 1991) with deviations from idealtwo unusual features. First, it assembles very rapidly in
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bond lengths and ideal bond angles of 0.013 AÊ and 1.668, respec- Guegan, N. Levy, J.-P, Guillet, J.G. and Gomard, E. (1994), Identifica-
tion of multirestricted immunodominant regions recognized by cyto-tively, and 91.5% of residues in most favored areas of the Ramacha-
dran plot. lytic T lymphocytes in the human immunodeficiency virus type 1
Nef protein. J. Virol. 68, 7336±7343.
Engh, R.A., and Huber, R. (1991). Accurate bond and angle parame-Analysis and Visualization
ters for X-ray protein-structure refinement. Acta. Cryst. A47,The quality of the final structure was assessed in the program PRO-
392±400.CHECK (Laskowski et al., 1993) and atomic coordinates for struc-
tural comparisons were obtained from the Protein DataBank, Brook- Falk, K., RoÈ tzschke, O., Stevanovic, S., Jung, G., and Rammensee,
haven National Laboratory. Structural superpositions were H.G. (1991). Allele-specific motifs revealed by sequencing of self-
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